Loading...
XSWX
VBSN
Market cap405mUSD
Dec 05, Last price  
136.00CHF
1D
-1.09%
1Q
-2.86%
Jan 2017
-32.91%
IPO
59.91%
Name

IVF Hartmann Holding AG

Chart & Performance

D1W1MN
XSWX:VBSN chart
P/E
16.08
P/S
2.06
EPS
8.46
Div Yield, %
3.68%
Shrs. gr., 5y
0.21%
Rev. gr., 5y
2.85%
Revenues
159m
+7.33%
113,614,000108,354,000106,717,000103,956,000113,673,000117,608,000118,594,000125,998,000125,434,000132,939,000132,288,000134,693,000133,449,999134,049,000137,998,000172,919,000144,067,000150,649,000147,953,000158,792,000
Net income
20m
+34.02%
4,281,0004,423,0004,754,0006,188,00010,359,00012,380,00013,166,00014,815,00015,346,00015,777,00016,091,00016,447,00016,010,00014,070,00012,169,00017,825,0006,209,00011,225,00015,148,00020,302,000
CFO
20m
-39.70%
10,032,00010,397,0004,993,00012,261,00010,321,00016,317,00015,982,00015,815,00017,775,00016,771,00020,642,00018,488,00016,642,00013,444,00018,020,00030,888,000-2,511,00017,719,00033,825,00020,398,000
Dividend
Apr 25, 20245 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company offers surgical disposable instruments, blankets, clothing and gloves, disinfection and hygiene products, wound management and hydrotherapy services, incontinence management, and first aid products, as well as various courses. It serves private doctors; outpatient medicine and care; hospitals and clinics; pharmacies and drugstores; nursing homes; and medical and food retailers, as well as industrial customers. The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993. The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland.
IPO date
Jul 16, 2012
Employees
293
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT